Seizure News and Research

Latest Seizure News and Research

Barr Labs and Par Pharmaceutical settle Diazepam patent case with Valeant

Barr Pharmaceuticals, Inc. today announced that its Barr Laboratories, Inc. subsidiary and Par Pharmaceutical Companies, Inc. have entered into a settlement agreement regarding their joint patent challenge with Valeant Pharmaceuticals North America related to Valeant's DIASTAT(R) diazepam rectal gel products.

15 Oct 2007

Generic Trileptal (oxcarbazepine) approved in U.S.

The U.S. Food and Drug Administration has approved the first generic versions of Trileptal (oxcarbazepine), an anticonvulsant drug.

10 Oct 2007

Migraine drug Topamax tested on alcoholics

Researchers in the United States say a drug used to prevent migraines has been effective in reducing the number of days alcoholics spend binge drinking.

10 Oct 2007

Brain eating amoeba in lake kills sixth victim

A Texas boy has become the sixth person this summer to die from brain eating amoeba.

7 Oct 2007

Mutation in a single gene can cause epilepsy in infants

New research from the Howard Florey Institute in Melbourne has shown why mutation in a single gene can cause epilepsy in infants.

4 Oct 2007

Research shows how genetic mutation causes epilepsy in infants

New research from the Howard Florey Institute in Melbourne has shown why mutation in a single gene can cause epilepsy in infants.

24 Sep 2007

FDA warns Procter and Gamble on hand sanitizer marketing

The U.S. Food and Drug Administration (FDA) has sent a warning letter to Procter & Gamble for making unlawful claims about its Vicks Early Defense Foaming Hand Sanitizer (Early Defense) product.

18 Sep 2007

E. Coli crops up again in lettuce from the U.S.

In yet another food scare in North America, Canadian consumers are being warned about contaminated lettuce.

17 Sep 2007

N-cofilin molecule protects from neuronal disorders

Many neuronal disorders, including epilepsy, schizophrenia and lissencephaly – a form of mental retardation - result from abnormal migration of nerve cells during the development of the brain.

17 Sep 2007

Study of new epilepsy treatment underway at URMC

The University of Rochester Medical Center (URMC) is participating in a multi-center study of a new medical device to treat epilepsy. The Rochester study is being overseen by neurologists Michel Berg, M.D. and James Fessler, M.D., and neurosurgeons Web Pilcher, M.D., Ph.D. and Jason Schwalb, M.D.

15 Sep 2007

Breast cancer drug tamoxifen helps treat symptoms of bipolar disease

Government researchers in the United States have found that the breast cancer drug tamoxifen helped treat the manic symptoms of bipolar disease.

13 Sep 2007

No evidence that Aspartame non-nutritive sweetener causes cancer

A sweeping review of research studies of aspartame says there is no evidence that the non-nutritive sweetener causes cancer, neurological damage or other health problems in humans.

12 Sep 2007

A neurostimulator device that detects, stops seizures under study at Medical College of Georgia

A small device implanted in the skull that detects oncoming seizures, then delivers a brief electrical stimulus to the brain to stop them is under study at the Medical College of Georgia.

11 Sep 2007

FDA warns Melanocorp for illegal sale of Melanotan II

The U.S. Food and Drug Administration (FDA) has issued a Warning Letter to Brian Manookian, owner of Melanocorp, Inc. in Hendersonville, Tenn. for the illegal sale and marketing of the product Melanotan II, which is not FDA-approved, on Melanocorp's Web site.

5 Sep 2007

Ovation Pharmaceuticals advances development pipeline with new phase III epilepsy study

OVATION Pharmaceuticals, Inc. announced the initiation of a pivotal Phase III clinical trial evaluating clobazam, a unique 1,5 benzodiazapine with significant anticonvulsant properties, as adjunctive treatment for patients with Lennox-Gastaut syndrome (LGS), one of the most severe forms of childhood epilepsy that frequently persists into adulthood.

5 Sep 2007

Scientists induce out-of-body-like experiences

Using virtual reality goggles to mix up the sensory signals reaching the brain, scientists have induced out-of-body-like experiences in healthy people, suggesting a scientific explanation for a phenomenon often thought to be a figment of the imagination.

24 Aug 2007